Santhera Pharmaceuticals Holding AG (S3F0)
XSTU
Closed
Oct 13, 2026
Day's Range
14.6252 wk Range
10.02Overview - S3F0 - Santhera Pharmaceuticals Holding AG
Key Statistics
Valuation
Enterprise Value
26.50M
P/E (Trailing)
‪-3.97‬
EV / EBITDA
‪-0.75‬
Profitability
Profit Margin
‪19.65%‬
Operating Margin
‪-48.57%‬
Return on Assets
‪-33.24%‬
Return on Equity
‪416.68%‬
Ownership
Shares Outstanding
13.39M
Price stats
50-Day Avg
‪16.55‬
200-Day Avg
‪16.78‬
Peers - S3F0 - Santhera Pharmaceuticals Holding AG
Peer Comparison
Compared with companies in Biotechnology listed on XSTU.
- S3F0XSTUSanthera Pharmaceuticals Holding AG+31.56%52-week change-3.97P/E (Trailing)‪19.65%‬Profit Margin
- 0QFXSTUModerna Inc.+85.97%52-week change-23.23P/E (Trailing)‪54.83%‬Profit Margin
- 2LBXSTUIovance Biotherapeutics Inc.+85.40%52-week change-12.00P/E (Trailing)‪34.27%‬Profit Margin
- 3920XSTUSpyre Therapeutics, Inc.+83.21%52-week change-40.91P/E (Trailing)—Profit Margin
- 0MEXSTUTwist Bioscience Corporation+80.24%52-week change-106.50P/E (Trailing)‪50.72%‬Profit Margin
- 3O8XSTUOmeros Corp.+76.73%52-week change-329.00P/E (Trailing)—Profit Margin
- 7R8XSTUReplimune Group, Inc.+65.72%52-week change-3.40P/E (Trailing)—Profit Margin
Profile Summary - S3F0 - Santhera Pharmaceuticals Holding AG
About
Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company headquartered in Pratteln, Switzerland, dedicated to the research, development, and commercialization of innovative medicines for patients with rare and debilitating diseases. The company primarily targets unmet medical needs in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
